Amring Pharmaceuticals Inc: Drug Recall
Recall #D-0871-2023 · 06/12/2023
Class III: Low Risk
Recall Details
- Recall Number
- D-0871-2023
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Amring Pharmaceuticals Inc
- Status
- Terminated
- Date Initiated
- 06/12/2023
- Location
- Berwyn, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 48,989 bottles
Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Product Description
Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30
Distribution Pattern
Nationwide in the USA.
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.